A promotional image with a doctor and the title "PHARMA BRANDING STRATEGIES 2025.

How Pharma Marketing Teams Actually Win: Pharma Branding Strategies 2025

In today’s competitive healthcare market, pharma branding strategies are no longer just about promoting a product, they’re about building trust, credibility, and long-term value. With the rise of digital-first communication and increasing regulatory scrutiny, pharmaceutical marketing teams must adopt smarter, patient-centric, and evidence-based approaches. This comprehensive guide explores the latest pharma branding strategies in 2025…

Healthcare professionals engaging in discussion with patient, overlaid with medical icons and text highlighting strategies in content creation in healthcare, emphasizing insightful and empowering healthcare content by eMediWrite.

Strategies That Work: The Role of Content Marketing in Healthcare

Content Marketing in Healthcare In today’s competitive pharma landscape, standing out is tough. Doctors and patients are flooded with information daily. This is where content marketing in healthcare makes the difference. Done strategically, it informs, builds trust, and drives recall. From patient guides to doctor webinars, the right content can elevate your brand credibility and…

eMediWrite at COSDERMINDIA 2025: Empowering Pharma Brands with Strategy, Science & Storytelling

COSDERMINDIA 2025 once again proved to be a premier convergence of innovation, science, and marketing brilliance in dermatology. Held in Delhi, the event brought together leading dermatologists, pharma leaders, skincare innovators, and medical communication experts. This year, the eMediWrite team had the privilege of being invited to meet with key marketing heads, brand managers, and senior leadership…

Nanomedicine in Indian Pharma: Status, Challenges, and Future

What Is Nanomedicine? Nanomedicine involves using nanoscale materials typically under 100 nm for diagnosis, treatment, monitoring, and control of biological systems. It enables drug delivery with high precision, reduced toxicity, and enhanced bioavailability, offering solutions to many limitations of conventional therapeutics. Current Landscape in India India’s nanomedicine journey is gaining momentum, though still in its…

Biosimilars vs. Biologics: The Science Every Indian Pharma Team Must Understand

Biologics: A New Era of Therapeutics Biologics are complex, large-molecule drugs made using living cells. They include monoclonal antibodies, cytokines, and vaccines used to treat cancer, autoimmune diseases, and metabolic disorders. Unlike small-molecule drugs, biologics require advanced technology and stringent manufacturing controls. Examples like Herceptin (trastuzumab) for HER2-positive breast cancer and Humira (adalimumab) for autoimmune…

Pharmacogenomics in India: Is Personalized Medicine the Future?

The Promise of Precision Pharmacogenomics, the study of how genetic differences affect drug responses, is reshaping modern medicine. Tailoring treatments to an individual’s genetic makeup it offers more effective, safer therapies. In India, home to vast genetic diversity, pharmacogenomics could revolutionize healthcare. But challenges in access, awareness, and infrastructure remain. Genetic Diversity: Strength and Challenge…

What\’s New In This Financial Year for Pharma Brands: How They Are Getting Smarter with AI and Automation

  The pharma industry is undergoing an exciting transformation. This year, pharma brands aren’t just talking about AI and automation as futuristic buzzwords; they’re using these tools to create real, meaningful change for patients and healthcare providers. Helping Patients Before They Even Know They Need Help AI-powered predictive analytics are enabling brands to understand patient…

5 Tips That Ensure Your Medical Communication Agency Provides Quality Medico-Marketing Promotions on Time

Tight timelines, legal requirements, and competitive brand positioning are all integral to the job description of a pharmaceutical marketer. Product launches can be derailed and brand reputations harmed by delays in medical content or subpar deliverables. How can you ensure your medical communication agency doesn’t act as a roadblock, but rather as a growth partner? These…